Onkologie. 2008:2(4):246-248

SUBCUTANEOUS ADMINISTRATION OF DRUGS AND FLUIDS IN PALLIATIVE MEDICINE

Ondřej Sláma
Ambulance podpůrné a paliativní onkologie, Masarykův onkologický ústav, Brno

Difficulties in intake of drugs and fluids per os are very often in patients with advanced stages of malignant (however of non-malignant as well) diseases. Possible causes are nausea, vomiting, difficulties in swalloving, confusion and general weakness accompanied by negative attitude to peroral medication. Most of these patients became so candidates for parenteral application of drugs nad liquids.

Keywords: Key words: incurable disease, insufficient income per os, subcutaneous administration, hypodermoclysis.

Published: December 1, 2008  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Sláma O. SUBCUTANEOUS ADMINISTRATION OF DRUGS AND FLUIDS IN PALLIATIVE MEDICINE. Onkologie. 2008;2(4):246-248.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Fainsinger R, et al. The use of hypodermoclysis for rehydratation in terminally ill cancer patients., J. Pain Symptom Manag. 9: 1994; 298-302. Go to original source... Go to PubMed...
    2. Constans T, et al. Hypodermoclysis in dehydrated elderly patients: local effects with and without hyaluronidase., J Palliative Care. 7: 1991; 10-12. Go to original source... Go to PubMed...
    3. Walker P, et al. Subcutaneous clodronate: a study evaluating its efficacy in malignant hypercalcemia and local toxicity. Ann Oncol. 8, 1997; 915-916. Go to original source... Go to PubMed...
    4. Trissel LA. Handbook on Injectable Drugs (11e). American Society of Health-System Pharmacists, 2000.
    5. Bradley K. Swap data on drug compatibilities. Pharmacy in Practice. 1996; 6: 69-72.
    6. Grassby PF, Hutchings L. Drug combinations in syringe drivers. Palliative Medicine. 1997; 11: 217-224. Go to original source... Go to PubMed...
    7. Hutchinson HT, et al. Continuous subcutaneous analgesics and anti-emetics in domiciliary terminal care. Lancet. 1981; 6: 1279. Go to original source... Go to PubMed...
    8. Chandler SW, et al. Combined administration of opioids with selected drugs to manage pain and other cancer symptoms: initial safety screening for compatibility. Journal of Pain and Symptom Management. 1996; 12: 168-171. Go to original source... Go to PubMed...
    9. Bradshaw K. Chemical compatibility and stability of morphine when mixed with various other injections. Therapeutic Goods Administration, Commonwealth Department of Health, Australia. Laboratory Information Bulletin. July 1992; 4: 1.
    10. Ross JR, et al. A prospective, within-patient comparison between metal butterfly needles and Teflon cannulae in subcutaneous infusion of drugs to terminally ill hospice patients. Palliative Medicine. 2002; 16: 13-16. Go to original source... Go to PubMed...
    11. Sláma O, Kabelka L, Vorlíček J eds. Paliativní medicína pro praxi. Praha: Galén, 2007; 365 s.

    Return to the content


    Oncology

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.